spacer
home > epc > Winter 2011
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2011
   
Text
PDF
bullet
Marketplace & Business

Editorís Letter

Dr Graham Hughes considers the increasing world population and its effect on the industry.

 
view
download pdf

Pharmaceuticals and the Environment

Strategies for Sustainability

As organisations come under increasing pressure to improve their green credentials, David Taylor at wca Environment considers how waste can be reduced throughout the pharma sector.

 
view
download pdf

R&D Growth

Survival of the Simplest

As pharmaceutical companies expand, they become increasingly complex organisations to change. Melvin Jay and Simon Collinson of the Simplicity Partnership suggest that companies should be aware of the problems that can arise as a result of unnecessary complexity in their structure.

 
view
download pdf

UK: R&D Sustainability

Reshaping Big Pharma

R&D has been hit hard by the global recession. Jonathan Trethowan of TRAC Services analyses the steps taken by large pharmaceutical companies to overcome these obstacles to productivity.

 
view
download pdf
bullet
Clinical Trials

Clinical Trial Management

Rules of Engagement

Michael Hantzperg of ICTA Systems explains how interim analysis allows for valuable reassessment points throughout a clinical trial.

 
view
download pdf
bullet
Legal & Regulatory

Medical Imaging: FDA Guidance

Image Conscious

Paul A van Meurs and Colin G Miller at BioClinica Inc analyse the FDA guidance on the use of medical imaging for endpoints in clinical trials, and suggest that a charter should be integral to image interpretation.

 
view
download pdf
bullet
Clinical Research

Real-World Studies

Gathering the Evidence

Krista Payne, Sallyanne Williams and Jess Sohal at United BioSource Corporation suggest that planning evidence generation at the start of the research process is the best approach to take.

 
view
download pdf
bullet
e-Data

Electronic Health Records

Setting the Standard

Jeffrey Cohen and Joshua Pines at Medidata Solutions explore steps that have been taken to integrate clinical technologies with electronic health records management.

 
view
download pdf

Electronic Trial Master Files

Digital Solutions

Karen Redding at Phlexglobal Ltd assesses the transfer from paper to electronic trial master files and highlights the advantages and risks of this technology.

 
view
download pdf
bullet
Biomarkers & Drug Development

Logistics: Biomarkers

The Right Path

Despite the advances in biomarker technology, are biomarkers being used to their full potential? Russ Hager at BioStorage Technologies suggests that improved cold chain management and facilities will help encourage their application.

 
view
download pdf

Drug Discovery: Biomarkers

Making your Mark

Biomarker discovery and development is a complex process which requires a comprehensive study design to ensure that the right information is obtained, as Bob Holt at Tepnel Pharma Services, Gen-Probe discusses.

 
view
download pdf
bullet
Therapeutics

Respiratory & Ocular Drug Development

Up to the Challenge

Anne Marie Salapatek, Victoria Nelson, Natasha Camuso and Fiona Soong at Cetero Research weigh up the most effective ways of testing the efficacy of respiratory and ocular treatments.

 
view
download pdf
bullet
Clinical Laboratories & Logistics

Clinical Supply Chain

Stretched to the Limit

Petra Bielmeier at F Hoffman La-Roche Ltd, and Geert Crauwels and Jim Williams at Lodestone MC discuss how best to overcome the pressures facing the clinical supply chain.

 
view
download pdf
bullet
Data Management & IT Solutions

Data Management: Cloud Computing

Up in the Clouds

Subhro Mallik at Infosys explores the benefits of cloud computing for the pharmaceutical industry and how adopting the right model can allow for the secure storage of important data.

 
view
download pdf

IT: Cloud Computing

Pharma Forecasting

The benefits of transferring to a cloud computing system have been discussed widely in recent years. However, as Thierry Grenot at Ipanema Technologies explains, this IT solution also has a number of disadvantages which must be appreciated.

 

 
view
download pdf
bullet
Central Labs

Central Laboratories

Drug Development Enters a New Era

The role of central laboratories is changing. Arnold Verbeek at Clinical Reference Laboratory Inc comments on how central labs have responded to globalisation and the trend towards personalised medicine.

 
view
download pdf
bullet
Manufacturing Environment

Packaging: Green Approaches

Perfecting Packaging

Intelligent and well-designed packaging and logistics services are playing their part to improve the sustainability of pharmaceutical companies, as Karen Adams and Roland Nicholas at SCA Cool Logistics discuss.

 
view
download pdf
bullet
Cool Chain, Labs & Logistics

Global Clinical Supply Chain

Fragile Goods

Globalisation of clinical trials and the growing number of temperature-sensitive materials calls for tighter management of the supply chain, as Alex Klim of DHL Supply Chain explores.

 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

BioIVT Introduces New Quality Management System to Maintain Highest Quality Biospecimens and Drug Development Research Services

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is introducing a new internal cloud-based Quality Management System (QMS), Master Control. This new standardized, ISO compliant QMS will help BioIVT manage documentation, auditing, supplier and customer accounts, and risk across all locations. It will consolidate and replace a variety of computer- and paper-based document control systems located at existing and newly-acquired BioIVT sites in the US, Europe and Asia.
More info >>

White Papers

Personalised Medicine - Pharma and Dx Firms Share Wider Horizons

DiagnostikNet-BB

Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >>

Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europeís Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont≠ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement